The Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program: Our Impact

Nancy Ngum and Paul Tanui (AUDA-NEPAD), Ms. Mimi Darko (Ghana FDA), and Kate Kikule (MTaPS)

Regional regulatory leaders, representatives from academia, and development organizations gathered in Accra, Ghana, in June to review a new monitoring and evaluation (M&E) tool that promises to improve access to safe, affordable medicines in several African countries by measuring the performance of Regional Centres of Regulatory Excellence (RCOREs).The African Union Development Agency (AUDA-NEPAD), in collaboration with the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program, supported the validation of the M&E tool.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

What is the purpose of the USAID-funded Medicines, Technologies, and Pharmaceuticals Services (MTaPS) program, and what will the program accomplish?MTaPS recently published a collection of brief publications that provide information on the program’s objectives and planned activities.